tiprankstipranks
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market

Dawnrays Pharmaceutical Holdings Ltd. (2348) Income Statement

Compare
2 Followers

Dawnrays Pharmaceutical Holdings Ltd. Income Statement

Last quarter (Q4 2023), Dawnrays Pharmaceutical Holdings Ltd.'s total revenue was ¥501.23M, a decrease of -9.94% from the same quarter last year. In Q4, Dawnrays Pharmaceutical Holdings Ltd.'s net income was ¥70.06M. See Dawnrays Pharmaceutical Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 1.15B¥ 1.28B¥ 1.17B¥ 1.02B¥ 950.01M
Gross Profit
¥ 641.52M¥ 766.68M¥ 675.36M¥ 545.55M¥ 522.75M
Operating Expenses
¥ 641.52M¥ 347.75M¥ 255.63M¥ 226.89M¥ 220.88M
Depreciation and Amortization
¥ 83.89M¥ 66.41M¥ 57.55M¥ 59.58M¥ 53.43M
EBITDA
¥ 498.94M¥ 505.19M¥ 433.89M¥ 395.71M¥ 341.59M
Operating Income
¥ 431.38M¥ 410.03M¥ 380.76M¥ 320.50M¥ 290.36M
Other Income/Expenses
¥ -17.33M¥ -5.87M¥ 42.38M¥ -4.54M¥ 7.38M
Pretax Income
¥ 414.06M¥ 438.41M¥ 439.32M¥ 331.30M¥ 314.09M
Net Income
¥ 326.00M¥ 358.06M¥ 358.18M¥ 268.13M¥ 255.43M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 0.22¥ 0.24¥ 0.24¥ 0.17¥ 0.16
Diluted EPS
¥ 0.22¥ 0.24¥ 0.24¥ 0.17¥ 0.16
Weighted Average Shares Outstanding
1.50B 1.50B 1.50B 1.54B 1.58B
Weighted Average Shares Outstanding (Diluted)
1.50B 1.50B 1.51B 1.55B 1.58B
Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis